Interview, Fireside Chat
Meme Lord CEO Raises $22.5M Series A for Hello Patient
Fundraising & Product Announcement
- Hello Patient secured a $22.5 million Series A funding round led by Scale Venture Partners, with participation from original investors 8VC, Blink Capital, and Max Ventures.
- The funding process spanned three weeks, involving discussions with 20–25 firms, followed by diligence and a term sheet signed on the Friday of the third week.
- Additional strategic investors in the round include Alumni Ventures, Lord David Pryor (former UK NHS chairman), and Remus Capital.
- The company is launching a parody video series culminating in a spoof of the Sam Altman and Johnny Ive product announcement video to mark the Series A close.
- The CEO replicated the exact attire of Altman and Ive (gray sweater, blue jeans, Lego shoes, safari jacket) and even purchased a specific Banana Republic safari jacket on eBay for the parody.
- Hello Patient raised an initial $3.8 million seed round, followed by an extension from existing investors before the current Series A.
Company Strategy & Market Positioning
- Hello Patient builds conversational AI agents exclusively for patient-facing healthcare workflows, handling inbound answering, outbound appointment reminders, and website chatbots.
- The company targets five primary verticals: urgent care, primary care, ENT and allergy, mental/behavioral health, and med spas, with emerging expansion into vision and dental care.
- Adoptionship shifted significantly in Q1 2024 as providers grew comfortable with AI latency and voice quality, moving from skepticism to active experimentation.
- The company's competitive advantage lies in the "last 30%" of integration: custom triaging flows and deep practice management system integrations that generic agent builders cannot replicate.
- Current technology stack relies on OpenAI for models (deemed too smart/fast for competitors), Cartesia and ElevenLabs for voices, and Deepgram for transcription.
- Growth metrics include processing tens of thousands of conversations daily, with a 12-month goal to scale to millions of daily conversations across thousands of clinics.
- The business model utilizes flexible pricing strategies, including per-clinic monthly fees, per-patient volume fees, or usage-based models for texting/calls.
Regulatory & Technical Constraints
- The company is HIPAA compliant, signs Business Associate Agreements (BAAs) with all customers, and maintains high liability insurance to mitigate data leakage risks.
- Hello Patient avoids clinical decision-making, strictly focusing on administrative tasks like appointment booking and triage to transfer urgent cases to human staff.
- The technology is not currently regulated by specific specialty licenses, but operators must adhere to telephony communication laws regarding call timing and frequency.
- The CEO estimates AGI, defined as an agent capable of autonomously learning a new practice's entire workflow without custom prompting, is at least 5–7 years away.
- The firm argues that legacy EHRs (Epic, Oracle Health, Athena) are designed for billing rather than patient engagement, giving Hello Patient a 2–3 year head start in the patient engagement niche.
Founder Profile: Alex Cohen
- Alex Cohen has been fired or laid off from 11 distinct companies, including Astronomer, Elon Musk's teams (twice), Meta, CrowdStrike (for accidentally pulling server plugs), the Harris campaign, and Wendy's.
- His tenure at Wendy's ended after he proposed "search pricing" for menus, which was fired by leadership citing Elizabeth Warren's recent tweet on dynamic pricing.
- His departure from Carbon Health was voluntary after the company pivoted to clinic operations only, removing the need for a large software R&D team.
- Cohen has built a personal brand on Twitter with nearly 230,000 followers, generating an average of 5,000–10,000 likes on top posts and using satire as a primary marketing and networking tool.
- His social media presence has directly contributed to inbound leads, with healthcare providers reaching out after seeing his Twitter and LinkedIn content.
Biohacking & Personal Health Strategy
- Cohen is currently undergoing hormone optimization therapy (TRT) and experimenting with various peptides to improve muscle growth, recovery, and sleep.
- Specific peptides used include CJC-1295 and Ipamorelin for muscle growth, Tesamorelin for reducing visceral fat, VPC 1295 for injury recovery, and DSIP for deep sleep regulation.
- He utilizes GLP-1 agonists (such as Ozempic) at a micro-dose (half the starting dose, approx. 1.25mg weekly) to manage appetite without the side effects of higher doses.
- Cohen tracks health metrics rigorously using an Oura ring, Whoop, and EAT (Eat, Sleep, Train) app to measure the efficacy of peptide cycles.
- He notes the U.S. food system is a primary driver of poor health, citing obesity and hormonal imbalances exacerbated by processed foods and microplastics.
Future Outlook & Hiring
- Hello Patient is currently a team of 15–16 people and is actively hiring "Agent Architects" to bridge natural language processing with clinical workflow logic.
- The company is building a small engineering and implementation team in Mexico City to handle practice integrations.
- The CEO predicts that while core EHR platforms (Epic, Athena) will remain dominant for the next 3–5 years, an AI-native EHR that handles scribing, billing, and engagement may emerge after that period.
- The company aims to become the standard for patient engagement, leveraging the fact that 30% missed call rates in healthcare result in significant lost revenue.